USPTO serial 79421833
DR.NOON
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- REAMS, CHRISTOPHER THOMAS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with DR.NOON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rui Geissler
Rui Geissler Millen White Zelano & Branigan, P.C.2200 Clarendon Boulevard Suite 1400Arlington, VA 22201United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Retinal cameras other than for medical use; tonometers for measuring, not for medical purposes; biometric retinal scanners; downloadable application software for smartphones featuring information for use in ophthalmic disease diagnosis, surgery and treatment; microscope for ophthalmic surgery; humanoid robot equipped with artificial intelligence for ophthalmic diagnosis, surgery and treatment; downloadable artificial intelligence program and software featuring information for use in ophthalmic disease diagnosis, surgery and treatment; recorded artificial intelligence program and software featuring information for use in ophthalmic disease diagnosis, surgery and treatment; wearable computer equipped with artificial intelligence which provides information for ophthalmic disease diagnosis, surgery and treatment; computers equipped with artificial intelligence which provides information for ophthalmic disease diagnosis, surgery and treatment; downloadable software for analyzing medical images for use in disease diagnosis and for use in medical decision support systems; computers and computer hardware for medical purposes; humanoid robots with artificial intelligence for use in scientific research; computers and computer hardware; downloadable computer software for collecting, processing, analyzing, managing, storing, and displaying data and digital images; recorded computer software for collecting, processing, analyzing, managing, storing, and displaying data and digital images; computer servers; peripherals adapted for use with computers; wearable computers in the nature of smartwatches and smartglasses; downloadable computer application software for smartphones, namely, software for collecting, processing, analyzing, managing, storing, transmitting, and displaying data and digital images; recorded software for analyzing medical images for use in disease diagnosis and for use in medical decision support systems | ACTIVE | — |
| 035 | Systematization of data in computer databases; wholesale store services featuring data processing software; retail store services featuring data processing software; compiling of information into computer databases; collection and systematisation of information into computer databases; wholesale store services featuring artificial intelligence programs and software for medical use; retail store services featuring artificial intelligence programs and software for medical use; sales agency services, namely, retail services by direct solicitation by sales agents featuring artificial intelligence programs and software for medical use; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; sales agency services, namely, retail services by direct solicitation by sales agents for medical apparatus and instruments; marketing the medical device goods of others; wholesale store services featuring apparatus for analysing images for medical use; retail store services featuring apparatus for analysing images for medical use; sales agency services, namely, retail services by direct solicitation by sales agents and wholesale and retail distribution services for apparatus for analysing images for medical use; wholesale store services featuring software for diagnosing diseases for medical purposes; retail store services featuring software for diagnosing diseases for medical purposes; sales agency services, namely, retail services by direct solicitation by sales agents for software for diagnosing diseases for medical purposes; wholesale store services featuring software for use in medical decision support systems; retail store services featuring software for use in medical decision support systems; sales agency services, namely, retail services by direct solicitation by sales agents for software for use in medical decision support systems; wholesale store services featuring software for diagnosing ocular diseases; retail store services featuring software for diagnosing ocular diseases; sales agency services, namely, retail services by direct solicitation by sales agents featuring software for diagnosing ocular diseases; wholesale store services featuring software for diagnosing cardiovascular diseases; retail store services featuring software for diagnosing cardiovascular diseases; sales agency services, namely, retail services by direct solicitation by sales agents featuring software for diagnosing cardiovascular diseases; wholesale store services featuring software for diagnosing kidney diseases; retail store services featuring software for diagnosing kidney diseases; sales agency services, namely, retail services by direct solicitation by sales agents featuring software for diagnosing kidney diseases; wholesale store services featuring software for providing information relating to health; retail store services featuring software for providing information relating to health; sales agency services, namely, retail services by direct solicitation by sales agents featuring software for providing information relating to health; electronic data processing services relating to health care information; wholesale store services featuring apparatus for diagnosing cardiovascular diseases with artificial intelligence; retail store services featuring apparatus for diagnosing cardiovascular diseases with artificial intelligence; sales agency services, namely, retail services by direct solicitation by sales agents featuring apparatus for diagnosing cardiovascular diseases with artificial intelligence; wholesale store services featuring apparatus for diagnosing ocular diseases with artificial intelligence; retail store services featuring apparatus for diagnosing ocular diseases with artificial intelligence; sales agency services, namely, retail services by direct solicitation by sales agents featuring apparatus for diagnosing ocular diseases with artificial intelligence; wholesale store services featuring apparatus for diagnosing kidney diseases with artificial intelligence; retail store services featuring apparatus for diagnosing kidney diseases with artificial intelligence; sales agency services, namely, retail services by direct solicitation by sales agents featuring apparatus for diagnosing kidney diseases with artificial intelligence. | ACTIVE | — |
| 038 | Providing access to databases; transmission and reception of information and data via telecommunication networks; electronic transmission of digital image; providing user access to a global computer network via mobile devices; providing the transmission of information via on-line network; electronic transmission of text, photo and video via smartphone applications; electronic transmission and delivery of audio and visual content; providing access to proprietary collections of medical and health information via website; transmission and reception of database information via wired or wireless telecommunication networks; providing access to web sites featuring medical information on the internet; providing access to proprietary collections of information on the internet; transmission of information via the internet; transmission of information; transmission of data via a computer network; providing access to computer databases; providing of telecommunications connections for cloud services; provision of access to medical information via the internet. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 10, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 10, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 12, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 1, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 19, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 19, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 19, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 16, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 16, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 2, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 19, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 19, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 16, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 14, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 17, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |